Biogen
-
{
- All
- News
-
Samsung in Talks to Buy Alzheimer’s Drug Maker Biogen for $42 Billion: Report
- Thursday December 30, 2021
- Agence France-Presse
Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).
-
www.gadgets360.com
-
Alzheimer’s Drug Failure Leaves Scientists Seeking New Direction
- Friday March 22, 2019
- Author: Robert Langreth
Drugmakers have tried again and again to treat Alzheimer’s disease by targeting a compound in the brain known as beta amyloid.
-
www.ndtvprofit.com
-
Big Pharma Vs Big Pharma In Court Battles Over Biosimilar Drugs
- Sunday October 2, 2016
- Thomson Reuters
Biologics, manufactured in living cells, then extracted and purified, are more complex than traditional medicines and cannot be copied with precision, and so their knock-off versions are called biosimilars instead of generics.
-
www.ndtvprofit.com
-
Big Pharma Dominates Ranking Of Stocks With Best 5-year Returns
- Tuesday May 3, 2016
- Thomson Reuters
U.S. pharmaceutical companies dominated an annual global ranking of top 10 large-cap stocks with the best five-year returns, according to an analysis released on Tuesday by Boston Consulting Group.
-
www.ndtvprofit.com
-
Wall Street falls on broad weakness; Pfizer drags
- Monday April 7, 2014
US stocks fell on Monday, putting the S&P 500 on track for its biggest three-day drop in two months, as investors rotated into defensive names to protect against further declines.
-
www.ndtvprofit.com
-
The funds that saw Apple's decline coming
- Thursday January 31, 2013
The slump in Apple Inc's share price from its September high has badly dented the returns of hundreds of mutual funds that had maintained outsized holdings of the stock. But some went sour on the iPhone-maker just in time.
-
www.ndtvprofit.com
-
Samsung in Talks to Buy Alzheimer’s Drug Maker Biogen for $42 Billion: Report
- Thursday December 30, 2021
- Agence France-Presse
Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).
-
www.gadgets360.com
-
Alzheimer’s Drug Failure Leaves Scientists Seeking New Direction
- Friday March 22, 2019
- Author: Robert Langreth
Drugmakers have tried again and again to treat Alzheimer’s disease by targeting a compound in the brain known as beta amyloid.
-
www.ndtvprofit.com
-
Big Pharma Vs Big Pharma In Court Battles Over Biosimilar Drugs
- Sunday October 2, 2016
- Thomson Reuters
Biologics, manufactured in living cells, then extracted and purified, are more complex than traditional medicines and cannot be copied with precision, and so their knock-off versions are called biosimilars instead of generics.
-
www.ndtvprofit.com
-
Big Pharma Dominates Ranking Of Stocks With Best 5-year Returns
- Tuesday May 3, 2016
- Thomson Reuters
U.S. pharmaceutical companies dominated an annual global ranking of top 10 large-cap stocks with the best five-year returns, according to an analysis released on Tuesday by Boston Consulting Group.
-
www.ndtvprofit.com
-
Wall Street falls on broad weakness; Pfizer drags
- Monday April 7, 2014
US stocks fell on Monday, putting the S&P 500 on track for its biggest three-day drop in two months, as investors rotated into defensive names to protect against further declines.
-
www.ndtvprofit.com
-
The funds that saw Apple's decline coming
- Thursday January 31, 2013
The slump in Apple Inc's share price from its September high has badly dented the returns of hundreds of mutual funds that had maintained outsized holdings of the stock. But some went sour on the iPhone-maker just in time.
-
www.ndtvprofit.com